Willis C. Lee - 03 Dec 2021 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Vice Chairman & COO, Director
Signature
Willis C. Lee
Issuer symbol
EMMA
Transactions as of
03 Dec 2021
Net transactions value
+$2,628
Form type
4
Filing time
05 Jan 2022, 10:52:43 UTC
Previous filing
30 Nov 2021
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $770 +500 +0.2% $1.54* 256,074 03 Dec 2021 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $348 +200 +0.08% $1.74* 256,274 10 Dec 2021 Direct
transaction EMMA Common stock, $0.001 par value Purchase $760 +500 $1.52* 500 13 Dec 2021 By Fidelity Roth IRA FBO Willis C. Lee
transaction EMMA Common stock, $0.001 par value Purchase $750 +500 +100% $1.50* 1,000 17 Dec 2021 By Fidelity Roth IRA FBO Willis C. Lee
holding EMMA Common stock, $0.001 par value 228,394 03 Dec 2021 By Fidelity Traditional IRA FBO Willis C. Lee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.55, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).